Thomas R. Cannell
Net Worth
Last updated:
What is Thomas R. Cannell net worth?
The estimated net worth of Dr. Thomas R. Cannell is at least $2,087,813 as of 2 Mar 2023. He has earned $317,693 from insider trading and has received compensation worth at least $1,770,120 in Sesen Bio, Inc..
What is the salary of Thomas R. Cannell?
Dr. Thomas R. Cannell salary is $885,060 per year as Pres, Chief Executive Officer & Director in Sesen Bio, Inc..
How old is Thomas R. Cannell?
Dr. Thomas R. Cannell is 63 years old, born in 1962.
What stocks does Thomas R. Cannell currently own?
As insider, Dr. Thomas R. Cannell owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Sesen Bio, Inc. (SESN) | Pres, Chief Executive Officer & Director | 344,150 | $0 | $0 |
What does Sesen Bio, Inc. do?
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Thomas R. Cannell insider trading
Sesen Bio, Inc.
Dr. Thomas R. Cannell has made 3 insider trades in 2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 606,800 units of SESN stock on 2 Mar 2023. As of 2 Mar 2023 he still owns at least 344,150 units of SESN stock.
Sesen Bio key executives
Sesen Bio, Inc. executives and other stock owners filed with the SEC:
- Dr. Glen C. MacDonald (74) Chief Technology Officer
- Dr. Thomas R. Cannell (63) Pres, Chief Executive Officer & Director
- Ms. Monica Forbes (49) Chief Financial Officer & Treasurer